Enhanced Antisense Oligonucleotide Delivery Using Cationic Liposomes Grafted with Trastuzumab: A Proof-of-Concept Study in Prostate Cancer
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Enhanced Antisense Oligonucleotide Delivery Using Cationic Liposomes Grafted with Trastuzumab: A Proof-of-Concept Study in Prostate Cancer
Authors
Keywords
-
Journal
Pharmaceutics
Volume 12, Issue 12, Pages 1166
Publisher
MDPI AG
Online
2020-11-30
DOI
10.3390/pharmaceutics12121166
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Prototyping Trastuzumab Docetaxel Immunoliposomes with a New FCM-Based Method to Quantify Optimal Antibody Density on Nanoparticles
- (2020) A. Rodallec et al. Scientific Reports
- Liposome and immune system interplay: Challenges and potentials
- (2019) Fahimeh Zahednezhad et al. JOURNAL OF CONTROLLED RELEASE
- Docetaxel-trastuzumab stealth immunoliposome: development and in vitro proof of concept studies in breast cancer
- (2018) Anne Rodallec et al. International Journal of Nanomedicine
- Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
- (2018) Freddie Bray et al. CA-A CANCER JOURNAL FOR CLINICIANS
- From 3D spheroids to tumor bearing mice: efficacy and distribution studies of trastuzumab-docetaxel immunoliposome in breast cancer
- (2018) Anne Rodallec et al. International Journal of Nanomedicine
- Critical evaluation of quantification methods for oligonucleotides formulated in lipid nanoparticles
- (2017) Erik Oude Blenke et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- The Diagnosis and Treatment of Prostate Cancer
- (2017) Mark S. Litwin et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Lipid-oligonucleotide conjugates improve cellular uptake and efficiency of TCTP-antisense in castration-resistant prostate cancer
- (2017) Sara Karaki et al. JOURNAL OF CONTROLLED RELEASE
- Polymer therapeutics and the EPR effect
- (2017) Hiroshi Maeda JOURNAL OF DRUG TARGETING
- Diagnostic Gleason score and castration-resistant prostate cancer
- (2016) A. Jayaram et al. ANNALS OF ONCOLOGY
- Detection and analysis of nanoparticles in patients: A critical review of the status quo of clinical nanotoxicology
- (2016) Dimitrios Bitounis et al. BIOMATERIALS
- A Contemporary Prostate Cancer Grading System: A Validated Alternative to the Gleason Score
- (2016) Jonathan I. Epstein et al. EUROPEAN UROLOGY
- HER2 gene amplification in patients with prostate cancer: Evaluating a CISH-based method
- (2016) Nazanin Sharifi et al. Oncology Letters
- Pharmacokinetics, biodistribution and cell uptake of antisense oligonucleotides
- (2015) Richard S. Geary et al. ADVANCED DRUG DELIVERY REVIEWS
- The hallmarks of castration-resistant prostate cancers
- (2015) Maria Katsogiannou et al. CANCER TREATMENT REVIEWS
- Predicting the influence of liposomal lipid composition on liposome size, zeta potential and liposome-induced dendritic cell maturation using a design of experiments approach
- (2015) Peter C. Soema et al. EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS
- In vitro modeling of HER2-targeting therapy in disseminated prostate cancer
- (2014) JENNIE ANDERSSON et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- Biodistribution, Tumor Uptake and Efficacy of 5-FU-Loaded Liposomes: Why Size Matters
- (2014) Raphaelle Fanciullino et al. PHARMACEUTICAL RESEARCH
- Therapeutic antisense oligonucleotides against cancer: hurdling to the clinic
- (2014) Pedro M. D. Moreno et al. Frontiers in Chemistry
- Enhanced endosomal/lysosomal escape by distearoyl phosphoethanolamine-polycarboxybetaine lipid for systemic delivery of siRNA
- (2013) Yan Li et al. JOURNAL OF CONTROLLED RELEASE
- Quantification of cell surface proteins with bispecific antibodies
- (2013) C. Panke et al. PROTEIN ENGINEERING DESIGN & SELECTION
- Antibody–drug conjugates – a perfect synergy
- (2012) John R Adair et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- Tolerability, safety, pharmacokinetics, and efficacy of doxorubicin-loaded anti-EGFR immunoliposomes in advanced solid tumours: a phase 1 dose-escalation study
- (2012) Christoph Mamot et al. LANCET ONCOLOGY
- Targeting TCTP as a New Therapeutic Strategy in Castration-resistant Prostate Cancer
- (2012) Virginie Baylot et al. MOLECULAR THERAPY
- Pre-Targeting and Direct Immunotargeting of Liposomal Drug Carriers to Ovarian Carcinoma
- (2012) Julia Lehtinen et al. PLoS One
- State of the art in PEGylation: The great versatility achieved after forty years of research
- (2011) Gianfranco Pasut et al. JOURNAL OF CONTROLLED RELEASE
- Reciprocal repression between P53 and TCTP
- (2011) Robert Amson et al. NATURE MEDICINE
- PC3 is a cell line characteristic of prostatic small cell carcinoma
- (2011) Sheng Tai et al. PROSTATE
- Nab-paclitaxel in the treatment of metastatic breast cancer: a comprehensive review
- (2011) Alberto J Montero et al. Expert Review of Clinical Pharmacology
- Angiogenesis inhibitors in the treatment of prostate cancer
- (2010) Paul G Kluetz et al. EXPERT OPINION ON PHARMACOTHERAPY
- Anti-apoptotic protein TCTP controls the stability of the tumor suppressor p53
- (2010) Seung Bae Rho et al. FEBS LETTERS
- Fluorocarbon oligonucleotide conjugates for nucleic acids delivery
- (2010) Guilhem Godeau et al. MedChemComm
- Liposome-Encapsulated Anticancer Drugs: Still Waiting for the Magic Bullet?
- (2009) R. Fanciullino et al. CURRENT MEDICINAL CHEMISTRY
- Simultaneous Inference in General Parametric Models
- (2008) Torsten Hothorn et al. BIOMETRICAL JOURNAL
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started